within Pharmacolibrary.Drugs.ATC.S;

model S03BA03_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.72,
    Cl             = 3.4999999999999995e-06,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0014,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S03BA03_1</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Betamethasone is a potent synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties. It is used in the treatment of various inflammatory, allergic, and autoimmune disorders. It is approved and widely used in contemporary medicine, including formulations for ophthalmic, topical, and systemic use.</p><h4>Pharmacokinetics</h4><p>Estimated typical parameters for oral administration in adults (when used off-label), as no specific PK publication exists for oral betamethasone.</p><h4>References</h4><ol><li><p>Jobe, AH, et al., &amp; Jusko, WJ (2020). Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India. <i>Clinical and translational science</i> 13(2) 391–399. DOI:<a href=&quot;https://doi.org/10.1111/cts.12724&quot;>10.1111/cts.12724</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31808984/&quot;>https://pubmed.ncbi.nlm.nih.gov/31808984</a></p></li><li><p>Schmidt, AF, et al., &amp; Kemp, MW (2019). Oral antenatal corticosteroids evaluated in fetal sheep. <i>Pediatric research</i> 86(5) 589–594. DOI:<a href=&quot;https://doi.org/10.1038/s41390-019-0519-0&quot;>10.1038/s41390-019-0519-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31365919/&quot;>https://pubmed.ncbi.nlm.nih.gov/31365919</a></p></li><li><p>Krzyzanski, W, et al., &amp; Jusko, WJ (2021). Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women. <i>Journal of pharmacokinetics and pharmacodynamics</i> 48(2) 261–272. DOI:<a href=&quot;https://doi.org/10.1007/s10928-020-09730-z&quot;>10.1007/s10928-020-09730-z</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33389521/&quot;>https://pubmed.ncbi.nlm.nih.gov/33389521</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S03BA03_1;
